![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ST. PAUL PHARMACEUTICAL ANNOUNCES DISTRIBUTION AGREEMENT OF FERRAZONE
ST. PAUL PHARMACEUTICAL ANNOUNCES DISTRIBUTION AGREEMENT OF FERRAZONE
August 30, 2005
St. Paul Pharmaceutical, a pending merger partner with WENR Corp. (OTC:WNRC) (wenr.net), announced today that it signed a distribution agreement with Akzo Nobel of the Netherlands to distribute Ferrazone(R) to countries in southeast Asia. St. Paul's agreement includes the distribution of Ferrazone(R) in Viet Nam, Cambodia and Laos with a potential market of over 100 million people. Ferrazone(R) is Akzo Nobel's brand name for sodium iron (III) ethylenediaminetetraacetate (NaFeEDTA). It is also commonly known as sodium feredetate. Ferrazone(R) is an additive for food products including rice, coffee, tea and milk.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1042587XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct